MedPath

Airway Pressure Release Ventilation (APRV) Protocol Early Used in Acute Respiratory Distress Syndrome

Not Applicable
Conditions
Acute Respiratory Distress Syndrome
Interventions
Device: Nellcor Puritan Bennett 840 ventilator system
Registration Number
NCT02639364
Lead Sponsor
West China Hospital
Brief Summary

The aim of this study is to assess the effects and safety of the early application of BILEVEL-APRV protocol and conventional ventilation strategy that used low tidal volume and adequate PEEP level in ARDS patients .

Detailed Description

Although mechanical ventilation is life-sustaining for patients with ARDS, it can perpetuate lung injury. A number of recent advances have greatly improved in the mechanical ventilation strategies and treatment for acute respiratory distress syndrome (ARDS), however, Mortality remains high, even with the use of low tidal volume and adequate positive end expiratory pressure(PEEP). Numerous experimental showed that the BILEVEL-APRV mode used in animal ARDS model can improve gas exchanges and hemodynamic tolerance of the ventilation while reducing the dosage for sedative drugs.

The aim of this single-center, prospective, randomized, controlled, open study is to compare the effects and safety of the early application of BILEVEL-APRV protocol and conventional ventilation strategy that used low tidal volume and adequate PEEP level in ARDS patients .

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Acute respiratory distress syndrome,according to the Berlin definition of ARDS, - The receipt of endotracheal mechanical ventilation for a period was no longer than 48 hours
  • A ratio of the partial pressure of arterial oxygen (PaO2) to the fraction of inspired oxygen(FiO2) was less than 250.
Exclusion Criteria
  • Pregnancy
  • The expected duration of mechanical ventilation was less than 48 hours
  • Intracranial hypertension (suspected or confirmed)
  • Neuromuscular disorders that are known to prolong the need for mechanical ventilation
  • Known or suspected chronic obstructive pulmonary disease(COPD)
  • Preexisting conditions with an expected 6-month mortality exceeding 50%
  • Pneumothorax (drained or not)at enrollment
  • Treatment with extracorporeal support (ECMO) at enrollment
  • There was a lack of commitment to life support.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BILEVEL-APRV protocolNellcor Puritan Bennett 840 ventilator systemAccording to our BILEVEL-APRV protocol, BILEVEL-APRV APRV mode with specific settings,combination with spontaneous breathing.
conventional ventilation strategyNellcor Puritan Bennett 840 ventilator systemThe conventional ventilation strategy use volume-controlled ventilation (VCV) or pressure-controlled ventilation (PCV) mode, combination with low tidal volume and adequate PEEP level.
Primary Outcome Measures
NameTimeMethod
Mechanical ventilation free daysday 28
Secondary Outcome Measures
NameTimeMethod
tidal volume(ml)Day 7
peak airway pressure,mean airway pressure,positive end expiratory pressure(cmH2O)day 7
number of patients requiring the use of noninvasive ventilationDay 28
static lung compliance(ml/cmH2O)Day 7
Blood pressure(mmHg)Day 7
PaO2,PaCO2(mmHg)Day 7
Duration of hospital stayday 60
number of patients requiring cointerventions and Adjunctive TherapiesDay 28
the tracheotomy rateDay 28
the number of days free from organ dysfunctionDay 28
minute ventilation (L)Day 7
all causes mortalityday 60

Participants will be followed for the duration of ICU stay

all cause hospital mortalityday 60

Participants will be followed for the duration of hospital stay, until day 60 maximum.

Average dosage of vasoactive drugs each day in useday 7
Number of patients with a pneumothoraxDay 28
blood lactic acid(mmol/l)Day 7
Richmond Sedation-Agitation Scaleday 7
Duration of stay in ICUday 60
Average dosage of sedative infusionday 7

Trial Locations

Locations (1)

Department of Critical care medicine of West China Hospital

🇨🇳

Chengdu, Sichuan, China

© Copyright 2025. All Rights Reserved by MedPath